Computed tomography of the brain was performed as part of the initial staging evaluation of 84 patients with small cell lung cancer. Brain scans indicative of metastatic disease were obtained in 12 (14% ) patients, two of whom had no neurologic signs or symptoms. One of these had no other extrathoracic disease. Brain scans without evidence of metastatic disease were obtained in 72 patients, 58 (80.5% ) of whom had no signs or symptoms suggestive of metastatic intracranial disease. In the 14 patients with neurologic symptoms but negative computed tomographic scans, other explanations than brain metastases were found. It was concluded that head scanning is a sensitive and accurate method of detecting c~ntral nervous system metastases in patients with small cell lung cancer. However, head computed tomography should not be included as part of the initial staging evaluation of the neurologically asymptomatic patients. In only one of 60 such patients did the brain scan change the initial clinical staging, which included chest films , liver and bone scans, and bone marrow biopsy.
About two-thirds of patients with small ce ll carc inoma (SCC) of th e lung have detectable metastatic disease at the time of diagnosi s [1] . Within thi s group , intracranial metastases are found during initial evaluati on in 10%-14 % [2 , 3] and ultimately occur in 30% -65 % in som e autopsy seri es [4 , 5] . To date, most SCC clinical trials have used the radionuclid e brain scan as a noninvasive means of detecting brain metastases [6] . Although valuable in neurologi cally symptom ati c patients [7] , the radionuclide scan has not proved useful as a scree nin g procedure in asymptomatic patients with lung cance r rega rdl ess of hi stolog ic c lassification [8] [9] [10] .
Computed tomography (CT) of the brain is a more sensitive meth od of detectin g cerebral metastases than is the radionuc lid e brai n scan [11 -1 3 ] . Conseq uently , head CT is frequently used as a sc reening procedure in th e stag ing evalu ation of asymptomatic patients with all histologi c types of lung cancer inc ludin g SCC . However, the usefulness of the CT brai n scan in the latter ro le has yet to be determined [6, 14] . We revi ewed our ex peri ence with head CT scans obtain ed as part of the initial pretreatment staging evalu ati on in 8 4 SCC pati ents see n at Vanderbilt University M edical Center. Th e re sults are th e subject of thi s report.
Materials and Methods
Eighty-four patients (average age 5 8 .8 yea rs; range 36 -79 years; 65 men, 19 women) with SCC histologica ll y or cytolog icall y co nfirmed by our path ology departm en t were th e subjects of thi s stud y. All pati ents we re evaluated at the Vanderb ilt Uni ve rsity Medical Center. Two patients had mi xed tumors, one w ith SCC-adenocarc in oma and one wit h SCC-squamous ce ll carc in oma. Neither of th e latter pati ents experi enced a brain metastasis. In addition to brain scans, eac h patien t underwe nt a stag in g evaluation that in c lu ded a hi story and physica l examinati on, chest fil m, comp lete blood ce ll co unt , screening blood c hemi stri es , radionuclide liver and bone scans, and bilateral posteri or ili ac c rest bone All CT images were ob tain ed on either a first generation 60 sec translate-rotate EMI-1 005 or a third generation 10 sec Omni 6000 scanner [1 5] . No fewer than eight adjacent 8 mm (EMI 1005) or 10 mm (Omni 6000) axial sections (about 20° with the canthomeatal line) were taken from the base to the apex of the skull, with special attent ion being paid to the posterior fossa and highest vertex cuts. All patients were imaged both before and after intravenous contrast enhancement with 50 ml of iot halamate meglumine 60% infused as a bolus immediately before im ag ing , followed by a rapid drip infusion durin g imaging of diatrizoate meglumine 30% or iothalamate meglumine 30%. Hard copy im ages were routinely obtained at a window level of 40 and a window width of 200 Hounsfield units (H).
All CT brain scans were rev iewed retrospectively by two of the authors (W. W. W. and D. H. J.) without prior knowledge of any of th e c linical or laboratory findings of the patients. The scans were interpreted in the following manner: (1) normal, no evidence of metastatic disease; (2) abnormal, compatible with metastasis; and (3) abnormal due to a nonmalignant pathologic process. For the purposes of this study, groups 1 and 3 are reported together. The CT criteria for metastasis were essentially the same as those used by Jacobs et al. [1 6] , with some modifications, and included: (1) primary, direct visual ization of a more or less well circumscribed, disc rete area of abnormal density; (2) secondary cerebral edema, mass effect with distortion , or collapse of spaces (e.g., ventricles) and shift of midline structures; and (3) multiple lesions. The neurologic examination was judged normal if a neurologic review of systems was negative and a screening neurologic examination, as described by Wittes and Yeh [9] and modified by us, proved normal (namely, deep tendon refl exes, plantar response, frontal lobe signs, crani al nerves, funduscopic examination, and assessment of gait and mental status).
Results
On the basis of the CT findings, the 84 SCC patients were divided into two groups: (1) patients with positive CT brain scans suggestive of metastatic disease, 12 (14%) patients and (2) patients with negative CT brain scans or with abnormalities that were clearly not metastatic in origin (e.g. , cerebral atrophy), 72 (86 %) patients. The mean age of group 1 patients was 62 years (range, 49-77 years) as compared with a mean age of 58 years (range , 36-79 years) in group 2 .
Two group 1 patients were neurologically asymptomatic. Both had multiple lesions on CT (figs. 1 and 2). Of the other 10 symptomatic patients , the CT abnormality correlated with the clinical neurologic findings in eight. Two patients had neurologic symptoms suggestive of an intracranial metastasis that was confirmed by CT but failed to correlate with the specific clinical findings (e .g., one patient had cerebellar signs bilaterally but a single right insular lesion) . Thus, 10 of the 12 patients with positive CT scans had cl inical findings that indicated the presence of intracranial metastatic disease , the specific location of which was predictable on the A 8 basis of c lin ical information in eight patients.
Six group 1 patients had single sites of central nervous system (CNS) metastatic disease, most often involving either the frontal or parietal lobes, while the six patients with multiple metastases usually had disease in both cerebral hemispheres. Five group 1 patients also had evidence of SCC outside of the thorax in addition to the CNS disease (liver, two ; bone marrow, one; bon e, one; and bone marrow plus bone, one) (table 2) . In th e other seven group 1 patients , the on ly metastati c disease detected was that noted on brain CT evaluation. Included within the latter seven pati ents was one of the neurologically asy mptomatic individu als. Thus, seven of 12 group 1 patients were extensive-stage disease by virtue of intracerebral metastas is alone.
In group 2, there were 16 patients with a positive bone marrow and 20 with positive li ver scans, 10 of whom also had positive marrows . Twenty-two patients had positive bone scans, eight of whom had no other site of metastatic d isease (table 2) .
Four group 1 patients had fo ll ow-up CT brain scans after completion ot" whole brain irradiation (3,000 rad [30 Gy] in 300 rad [3 Gy] frac tions over 2 weeks) plus systemic chemotherapy (cyc lophosphamide, adriamycin, and vincristine ± methotrexate) an average of 5 .5 months after diagnosis . Three patients were undergoing routine restaging and one was being evaluated for a new lung nodu le . Repeat CT scans were entirely normal in two of the patients, including the follow-up study of one of the asymptomatic patients at 5 months after diagnosis . The latter patient had a third head CT scan at 14 months after d iagnosis that was also neg ative ( fig . 2) . The other two restaging CT brain scans showed progression of metastati c d isease. One of the latter patients had been asymptomatic initial ly , and remained asymptomatic despite his worsening scan .
From a c linical perspective, there were 60 SCC patients, 39 w ith extensive-stage (outside thorax) and 21 with limitedstage (l imited to thorax) who were neurological ly asymptomatic. As noted , only two of these 60 neurolog ically intact individuals had a positive head CT scan. On the other hand , 24 SCC patients, 19 with extensive-stage, five with limitedstage, had abnormal neurologic evalu ations at diagnosis; 10 of them had positive head CT studies. Of the other 14 patients, two had neurolog ic abnormalities that were clearly peripheral in origin (i.e ., brac hial plexus involveme nt). Th e other 1 2 patients had signs or symptoms suggestive of possible brain invo lvement (e.g ., new onset headache, dementia, weakness , etc.), but no exp lanation was determined or the abnormality ultimately proved secondary to a metabolic derangement (e .g., IADH, hypercalcemia, ectopi c ACTH) or peripheral neurologic abnormal ity (e .g., polyneuropathy , either due to the underlying SCC or drug-induced). Thus, 22 of 24 neurologically symptomatic patients required head CT scans to complete ly delineate the nature of th eir symptoms. Ten of 22 had a CT brain scan suggesting metastasis.
Discussion
Staging patients with SCC currently is most useful in determining prognosis [6] . Patients with li mited-stage disease survive longer than those patients with detectable disease outside the thora x [1 -3 ] . Studies are still in progress to determine whether stage-specific therapy is warranted . If survival is improved by adding radiotherapy to the primary chest lesion in patients with limited-stage disease, th e routine determination of stage will be even more important. If therapeuti c cranial irradiation proves less effective than prophylactic crani al irrad iati on, an area of co ntroversy [17, 18] , th en establishin g th e presence or absence of cerebra l metastases also assumes greater importance . Central nervo us system metastases in SCC patients are usually intracrani al [6] , alth oug h spinal cord and leptomeningeal metastases are being reported more ofte n [4] . Whil e asy mpto mati c cere bral metastases occ ur as documented in autopsy seri es [4, 19] , more than 80 % are recognized c lini call y during life [14] . Both radionuclude brain scans and CT scans are sensitive and accurate methods of detecting ce rebral meta stases especially in neurologically symptomati c pati ents [ 7, 13] . Although occasionally neurologically asymptomati c lung cancer patients have radionuclide brain scans suggestive of intracrani al tumor, thi s procedure has not proved particu larly useful in the routine pretreatme nt evalu ation of the vast majority of such patients [4, [8] [9] [10] . For this reaso n, radionuclide brain scans shou ld not be routinely in c lud ed in the battery of pretreatm ent screen in g procedures obtained on asy mptomatic patients with lun g cance r [8] [9] [10] .
In studies where rad ionu c lide brain scans and CT scans have been prospectively compared, the latter appears to be more sensitive and specifi c for the detection of CNS metastases [11 , 12,2 0]. However, unlike radionuclide scans, very little is known about the value of CT brain scans in th e pretreatment investigation of neurolog ically asymptomatic patients w ith lun g cance r [16, 20] . Thi s is particu larly true in SCC [6, 14] . Usin g th e head CT sca n as a pretreatment screening procedure, Jacobs et al. [1 6 ] evaluated 50 neurolog ically intact patients with negative radionuclid e scans and lung cance r c lini call y co nfined to the th orax. In thi s settin g they found a 6 % in c idence of " silent " brain metastases inc luding o nl y one of 16 SCC patients who had an occult cerebe ll ar metastasis detected onl y with th e contrastenh anced CT. Jenning s et al. [21] reported a much higher inc id ence (21 % ) of c lini call y occult CNS les ions detected by preoperative CT brain scan in 102 neurologically asymptomatic pati ents with lung cancer. However, th ey did not define th e exte nt of thi s disease in th eir population nor were their patients preselected on the basis of a negative radionuclide scan . Unfortunately , th ese authors lumped all hi stologic types of lun g ca ncer together and did not specify the incidence of sil ent metastasis accordin g to specific tumor histo logy.
Comparabl e with other studies [2, 3] , we found a 14% in cidence of CNS metastases at initial diagnosis using the head CT scan. Howeve r, unlike th e findings of Jaco bs et al. [1 6 ] and Jennings et al. [21] , 10 of our 12 patients with positive CT scans had neurologic findings or complaints th at AJNR:3, November / Decem ber 1982 indi cated the presence of intracerebral disease. Both asymptomatic patients with positive CT scans had multiple albeit small lesions (figs . 1 and 2) located at various sites within the brain parenchyma. One asymptomatic patient demonstrated total resolution of the CT scan abnormalities after completion of whole brain irradiation ( fig . 2) . Also, one symptomatic patient demonstrated normalization of the CT scan following irradiation , at which point he had become asymptomatic. In addition to radiotherapy these patients received systemic chemotherapy as previously reported [22 , 23] . Although routine follow-up CT scans were not obtained on the other patients, these findings suggest that the head CT scan might be most useful in assessing tumor response to whole brain irradiation.
In a clinicopathologic evaluation of 209 SCC patients, Nugent et al. [4] found that patients with bone marrow or liver involvement at initial staging were more likely to develop CNS metastases than individuals without tumor in these sites. In our patient population , 17% with intracranial metastases at diagnosis had marrow involvement initially as compared with 22 .5% without CNS disease (p > 0 .5) . Likewise , there was no difference between the two groups of patients with respect to initial liver metastases (17 % versus 29 %; p > 0 .1). Nine initially asymptomatic patients eventually developed a positive CT brain scan (all of them became symptomatic, thus prompting the CT evaluation) ; only four of them had had either a positive bone marrow or liver scan at initial staging. Likewise, four patients who had had only a positive bone scan at diagnosis (which was not correlated with the subsequent development of CNS metastasis by Nugent et al. [4] ) developed brain metastases. Thus, in this small group of patients, there did not appear to be a correlation between CNS metastasis at initial staging or the subsequent development of intracerebral disease and the presence of liver or marrow involvement at diagnosis.
In summary , 60 of 84 patients with SCC who underwent head CT at the time of diagnosis were neurologically asymptomatic and 58 had negative screening CT evaluations. Of the asymptomatic patients, two had CT evidence of clinically occult CNS metastases, only· one of whom would have been inappropriately staged had a head CT scan not been done. Ten of our 12 patients with abnormal CT brain scans had symptoms or signs suggestive of CNS disease, and in eight the clinical findings correlated with the specific CT scan abnormality . These data do not differ from those reported by Wittes and Yeh [9] , who noted a 2 .8 % incidence of occult lesions using the radionuclide brain scan as a screening procedure for " silent " CNS metastases in SCC . Thus , we conclude that the CT examination of the brain should not be considered part of the initial routine staging evaluation of the neurologically intact patient with SCC .
